Global Testosterone Replacement Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Testosterone Replacement Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.
Testosterone Replacement Therapy report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Testosterone Replacement Therapy market is projected to reach US$ 1134.6 million in 2034, increasing from US$ 1526.5 million in 2022, with the CAGR of -4.1% during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
Global Testosterone Replacement Therapy key players include AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan) etc. Global top five manufacturers hold a share over 70%. North America is the largest market, with a share over 80%, followed by Europe and Asia (Ex. China) , both have a share over 10% percent.
In terms of product, Gels is the largest segment, with a share over 60%. And in terms of application, the largest application is Clinics, followed by Hospitals.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Testosterone Replacement Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
AbbVie
Endo International
Eli lilly
Pfizer
Actavis (Allergan)
Bayer
Novartis
Teva
Mylan
Upsher-Smith
Ferring Pharmaceuticals
Kyowa Kirin
Acerus Pharmaceuticals
Segment by Type
Gels
Injections
Patches
Other
Hospitals
Clinics
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Testosterone Replacement Therapy market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Testosterone Replacement Therapy, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Testosterone Replacement Therapy industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Testosterone Replacement Therapy in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Testosterone Replacement Therapy introduction, etc. Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Testosterone Replacement Therapy market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Testosterone Replacement Therapy report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Testosterone Replacement Therapy market is projected to reach US$ 1134.6 million in 2034, increasing from US$ 1526.5 million in 2022, with the CAGR of -4.1% during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
Global Testosterone Replacement Therapy key players include AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan) etc. Global top five manufacturers hold a share over 70%. North America is the largest market, with a share over 80%, followed by Europe and Asia (Ex. China) , both have a share over 10% percent.
In terms of product, Gels is the largest segment, with a share over 60%. And in terms of application, the largest application is Clinics, followed by Hospitals.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Testosterone Replacement Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
AbbVie
Endo International
Eli lilly
Pfizer
Actavis (Allergan)
Bayer
Novartis
Teva
Mylan
Upsher-Smith
Ferring Pharmaceuticals
Kyowa Kirin
Acerus Pharmaceuticals
Segment by Type
Gels
Injections
Patches
Other
Segment by Application
Hospitals
Clinics
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Testosterone Replacement Therapy market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Testosterone Replacement Therapy, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Testosterone Replacement Therapy industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Testosterone Replacement Therapy in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Testosterone Replacement Therapy introduction, etc. Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Testosterone Replacement Therapy market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.